Skip to content

Foley Bulb Insertion Method: Blind vs. Direct

Foley Bulb Insertion by Blind Placement Versus Direct Visualization: A Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03450408
Acronym
FrIENDly
Enrollment
372
Registered
2018-03-01
Start date
2018-02-28
Completion date
2019-08-01
Last updated
2020-05-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy Related

Brief summary

The investigators will compare, in a randomized clinical trial, two methods of placement (placement with a gloved hand vs. placement with a sterile speculum) of a Foley bulb transcervical dilator. The primary outcome is rate of infection.

Detailed description

The target population for this study is women who present for scheduled induction of labor. If there is a decision by the obstetric team to place a transcervical Foley dilator for cervical ripen-ning, the obstetric team will notify the research team so that the patient may be screened for the study. If the patient consents to participation, written informed consent will be obtained by person-to-person contact. The PI, study coordinator, or a collaborator will be responsible for the in-formed consent. After informed consent is obtained, the patient will be randomized to the study group (digital placement) or the control group (placement with a sterile speculum). The control group will undergo induction of labor by placement via sterile speculum of a 22-French transcervical Foley catheter. The cervix is visualized with a sterile vaginal speculum and cleaned with iodine or chlorhexidine. A Foley catheter is introduced into the cervix and the bal-loon is filled with 60 ml of sterile 0.9% NaCl. The Foley catheter will be left in place for at least 12 hours, and no longer than 24 hours. After placement standard intrapartum management of the patient will ensue. The study group will undergo induction of labor by digital blind placement of a 22-French trans-cervical Foley catheter. A Foley catheter is introduced into the cervix using digits and hands wearing sterile gloves and the balloon is filled with 60 ml of sterile 0.9% NaCl. The Foley catheter will be left in place for at least 12 hours, and no longer than 24 hours. After placement standard intrapartum management of the patient will ensue. If cervix remains unfavorable after extraction of the dilators (\< 3cm and at most 60% effaced), a second Foley catheter will be used in this case for a maximum of 12 hrs. No crossover will be allowed. In other words, a second Foley bulb will be placed in the same manner as the first assignment arm. In any attempts, if the Foley bulb is not able to be placed in either insertion technique , a prostaglandin agent for cervical ripening may be used and insertion of the mechanical dilator can be re-attempted at a later time, as is the standard of care at our institution. No cross over will be allowed. This will be an unblinded randomized clinical trial. No significant adverse effects are expected with the use of transcervical Foley catheters for mechanical dilation. The most significant risks are vaginal bleeding due to cervical trauma and incidental rupture of membranes, as well as pain or discomfort with placement. The patient will undergo inpatient induction of labor, so any adverse reaction would be promptly detected and addressed.

Interventions

PROCEDUREMethod of placement of Foley bulb transcervical dilator

This trial will assess two methods used to place a Foley bulb transcervical dilator.

Sponsors

The University of Texas Medical Branch, Galveston
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Masking description

The individual or individuals responsible for assessing outcome data will be blinded to group assignment.

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* Women between the ages of 18 and 50 years * Induction of labor * Plan for Foley bulb placement by the managing obstetrics team

Exclusion criteria

* Patient unwilling or unable to provide consent * Fetal demise or major congenital anomaly * Immunosuppressed patients: i.e., taking systemic immunosuppressants or steroids (e.g. transplant patients; not including steroids for lung maturity), HIV with CD4\<200, or other * Fever (\>38°C) in the 48 hours prior to presentation for induction of labor * Use of anti-pyretic agent (i.e., acetaminophen) in the eight hours preceding admission for induction of labor

Design outcomes

Primary

MeasureTime frameDescription
InfectionLabor to 30 days postpartumPooled maternal infection

Secondary

MeasureTime frameDescription
Request for pain reliefWithin 30 minutes of placement procedureRequest for IV pain medications or epidural placement
Vaginal bleedingWithin 30 minutes of placement procedureIn the time period immediately following placement
Maternal feverFrom beginning of labor process to time of discharge, up to seven daysGreater than or equal to 38 degrees Celsius
Chorioamnionitis or triple IFrom beginning of labor process until time of deliveryPresumptive or confirmed diagnosis
EndometritisFrom time of delivery to 30 days postpartumPostpartum intrauterine infection
Artificial rupture of membranesAt time of placement of Foley bulb transcervical dilatorRupture of amniotic sac

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 17, 2026